Fibrates, glitazones, and peroxisome proliferator-activated receptors. - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Arteriosclerosis, Thrombosis, and Vascular Biology Année : 2010

Fibrates, glitazones, and peroxisome proliferator-activated receptors.

Résumé

Several decades ago, fibrates were approved for the treatment of dyslipidemia, whereas thiazolidinediones were screened in animal models to improve glucose homeostasis and were subsequently developed for the treatment of type 2 diabetes mellitus. Relatively recently, these drugs were found to act via peroxisome proliferator-activated receptors, nuclear receptors that control lipid metabolism and glucose homeostasis. In this historical perspective, we discuss the history of discovery of the peroxisome proliferator-activated receptors, from the clinical development of their agonists to the subsequent discovery of these receptors and their mechanisms of action, to finally evoke possibilities of targeted pharmacology for future development of selective peroxisome proliferator-activated receptor modulators.
Fichier principal
Vignette du fichier
inserm-00475566_edited.pdf (147.36 Ko) Télécharger le fichier
LalloyerStaels_HistoryPPARs.pdf (125.59 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)
Origine : Fichiers produits par l'(les) auteur(s)
Loading...

Dates et versions

inserm-00475566 , version 1 (02-11-2010)

Identifiants

Citer

Fanny Lalloyer, Bart Staels. Fibrates, glitazones, and peroxisome proliferator-activated receptors.. Arteriosclerosis, Thrombosis, and Vascular Biology, 2010, 30 (5), pp.894-9. ⟨10.1161/ATVBAHA.108.179689⟩. ⟨inserm-00475566⟩
85 Consultations
659 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More